Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2018, Article ID 9601801, 19 pages
https://doi.org/10.1155/2018/9601801
Review Article

Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy

1Pulmonary and Critical Care Medicine Department, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
2Endocrine and Metabolic Research Center, University of Zulia, Maracaibo, Venezuela
3Grupo de Investigación Altos Estudios de Frontera (ALEF), Universidad Simón Bolívar, Cúcuta, Colombia
4Clinical Pharmacology Unit. School of Medicine José María Vargas, Central University of Venezuela, Caracas, Venezuela

Correspondence should be addressed to Juan Salazar; moc.liamtoh@81vsjnauj

Received 15 August 2017; Revised 15 November 2017; Accepted 6 December 2017; Published 19 February 2018

Academic Editor: Lucy Marzban

Copyright © 2018 Joselyn Rojas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Reichert and A. K. Rustgi, “Pancreatic ductal cells in development, regeneration, and neoplasia,” The Journal of Clinical Investigation, vol. 121, no. 12, pp. 4572–4578, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Fujimoto and K. S. Polonsky, “Pdx1 and other factors that regulate pancreatic β-cell survival,” Diabetes, Obesity and Metabolism, vol. 11, no. 4, pp. 30–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Scharfmann, B. Duvillie, V. Stetsyuk, M. Attali, G. Filhoulaud, and G. Guillemain, “β-cell development: the role of intercellular signals,” Diabetes, Obesity and Metabolism, vol. 10, no. 4, pp. 195–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Seino, T. Shibasaki, and K. Minami, “Dynamics of insulin secretion and the clinical implications for obesity and diabetes,” The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2118–2125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Rojas, V. Bermúdez, E. Leal et al., “Insulinorresistencia e hiperinsulinemia como factores de riesgo para enfermedad cardiovascular,” AVFT, vol. 27, no. 1, pp. 29–39, 2008. View at Google Scholar
  6. C. J. Rhodes and M. F. White, “Molecular insights into insulin action and secretion,” European Journal of Clinical Investigation, vol. 32, Supplement 3, pp. 3–13, 2002. View at Publisher · View at Google Scholar
  7. R. A. Bastarrachea, H. Laviada-Molina, I. Machado-Domínguez, J. Kent, J. C. López-Alvarenga, and A. G. Comuzzie, “El receptor de insulina como objetivo farmacogenómico: potenciando su señalización intracelular,” Revista de Endocrinología y Nutrición, vol. 13, no. 4, pp. 180–189, 2005. View at Google Scholar
  8. American Diabetes Association, “Standards of medical care in diabetes—2017: summary of revisions,” Diabetes Care, vol. 40, Supplement 1, pp. S4–S5, 2017. View at Publisher · View at Google Scholar
  9. G. Tosone, A. E. Maraolo, G. Palmiero, S. Mascolo, and R. Orlando, “Diabetes mellitus type 1, latent autoimmune diabetes of adults and hepatitis C virus: what we know and what we need to know,” Journal of Diabetes & Metabolism, vol. 4, no. 8, pp. 301–305, 2013. View at Publisher · View at Google Scholar
  10. T. L. Van Belle, K. T. Coppieters, and M. G. Von Herrath, “Type 1 diabetes: etiology, immunology, and therapeutic strategies,” Physiological Reviews, vol. 91, no. 1, pp. 79–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Salas, J. L. Santos, and F. Pérez, “Genetic of type 1 diabetes mellitus,” Revista Chilena de Endocrinología y Diabetes, vol. 6, no. 1, pp. 15–22, 2013. View at Google Scholar
  12. J. C. Wiebe, A. M. Wägner, and F. J. Novoa, “Genética de la diabetes mellitus,” Revista Nefrología, vol. 2, no. 1, pp. 111–119, 2011. View at Google Scholar
  13. P. Pirot, A. K. Cardozo, and D. L. Eizirik, “Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 52, no. 2, pp. 156–165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Cnop, N. Welsh, J. C. Jonas, A. Jörns, S. Lenzen, and D. L. Eizirik, “Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities,” Diabetes, vol. 54, no. Supplement 2, pp. S97–S107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Guay, C. Jacovetti, V. Nesca, A. Motterle, K. Tugay, and R. Regazzi, “Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction,” Diabetes, Obesity and Metabolism, vol. 14, no. 3, pp. 12–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. A. Ma, Z. Zhao, and J. Turk, “Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus,” Experimental Diabetes Research, vol. 2012, Article ID 703538, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Weckman, A. Di Ieva, F. Rotondo et al., “Autophagy in the endocrine glands,” Journal of Molecular Endocrinology, vol. 52, no. 2, pp. 151–163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Rojas, “Inflammasomes – fighting the enemy from within,” Avances en Biomedicina, vol. 1, no. 1, pp. 18–29, 2012. View at Google Scholar
  19. G. A. Rutter and F. S. Wong, “The pancreatic β-cell: birth, life and death,” Biochemical Society Transactions, vol. 36, no. 3, pp. 267–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Lernmark and H. E. Larsson, “Immune therapy in type 1 diabetes mellitus,” Nature Reviews Endocrinology, vol. 9, no. 2, pp. 92–103, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. F. A. Grant, H. Hakonarson, and S. Schwartz, “Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults?” Endocrine Reviews, vol. 31, no. 2, pp. 183–193, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Kantárová and M. Buc, “Genetic susceptibility to type 1 diabetes mellitus in humans,” Physiological Research, vol. 56, no. 3, pp. 255–266, 2007. View at Google Scholar
  23. Y. L. Wu, Y. P. Ding, J. Gao, Y. Tanaka, and W. Zhang, “Risk factors and primary prevention trials for type 1 diabetes,” International Journal of Biological Sciences, vol. 9, no. 7, pp. 666–679, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Ujvari and K. Belov, “Major histocompatibility complex (MHC) markers in conservation biology,” International Journal of Molecular Sciences, vol. 12, no. 12, pp. 5168–5186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Noble and H. A. Erlich, “Genetics of type 1 diabetes,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 1, article a007732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. P. Morran, G. S. Omenn, and M. Pietropaolo, “Immunology and genetics of type 1 diabetes,” Mount Sinai Journal of Medicine, vol. 75, no. 4, pp. 314–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Aguirre, J. Rojas, R. Cano, M. Villalobos, and L. Berrueta, “Diabetes mellitus tipo 1 y factores ambientales: la gran emboscada,” Revista Venezolana de Endocrinología y Metabolismo, vol. 10, no. 3, pp. 122–135, 2012. View at Google Scholar
  28. A. K. Steck and M. J. Rewers, “Genetics of type 1 diabetes,” Clinical Chemistry, vol. 57, no. 2, pp. 176–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. A. A. G. Tantawy, “Immunogenetics of type 1 diabetes mellitus,” Egyptian Journal of Pediatric Allergy and Immunology, vol. 6, no. 1, pp. 3–12, 2008. View at Google Scholar
  30. K. L. Mehers and K. M. Gillespie, “The genetic basis for type 1 diabetes,” British Medical Bulletin, vol. 88, no. 1, pp. 115–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Bakay, R. Pandey, and H. Hakonarson, “Genes involved in type 1 diabetes: an update,” Genes, vol. 4, no. 3, pp. 499–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Vehik and D. Dabelea, “Why are C-section deliveries linked to childhood type 1 diabetes?” Diabetes, vol. 61, no. 1, pp. 36-37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Rode and O. Díaz, “Cow milk consumption, immune response and type 1 diabetes mellitus,” Revista Cubana de Endocrinología, vol. 20, no. 2, pp. 1–7, 2009. View at Google Scholar
  34. P. Betts, J. Mulligan, P. Ward, B. Smith, and T. Wilkin, “Increasing body weight predicts the earlier onset of insulin-dependent diabetes in childhood: testing the ‘accelerator hypothesis’ (2),” Diabetic Medicine, vol. 22, no. 2, pp. 144–151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. D. La Torre and A. Lernmark, “Immunology of β-cell destruction,” Advances in Experimental Medicine and Biology, vol. 654, pp. 537–583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. P. In't Veld, “Insulitis in human type 1 diabetes: the quest for an elusive lesion,” Islets, vol. 3, no. 4, pp. 131–138, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Zhang, M. Nakayama, and G. S. Eisenbarth, “Insulin as an autoantigen in NOD/human diabetes,” Current Opinion in Immunology, vol. 20, no. 1, pp. 111–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Nakayama, “Insulin as a key autoantigen in the development of type 1 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 27, no. 8, pp. 773–777, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. W. Yoon and H. S. Jun, “Autoimmune destruction of pancreatic β cells,” American Journal of Therapeutics, vol. 12, no. 6, pp. 580–591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. J. F. Bach and L. Chatenoud, “Tolerance to islet auto-antigens in type I diabetes,” Annual Review of Immunology, vol. 19, no. 1, pp. 131–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. W. E. Winter and D. A. Schatz, “Autoimmune markers in diabetes,” Clinical Chemistry, vol. 57, no. 2, pp. 168–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Nair, T. R. Wolter, A. J. Meyers, and D. Zipris, “Innate immune pathways in virus-induced autoimmune diabetes,” Annals of the New York Academy of Sciences, vol. 1150, no. 1, pp. 139–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Thivolet, “Beta cells in type 1 diabetes: victims or activators of t cell response?” Diabetes & Metabolism, vol. 28, no. 4, pp. 267–269, 2002. View at Google Scholar
  44. M. Li, L. J. Song, and X. Y. Qin, “Advances in the cellular immunological pathogenesis of type 1 diabetes,” Journal of Cellular and Molecular Medicine, vol. 18, no. 5, pp. 749–758, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. D. L. Eizirik, M. L. Colli, and F. Ortis, “The role of inflammation in insulitis and β-cell loss in type 1 diabetes,” Nature Reviews Endocrinology, vol. 5, no. 4, pp. 219–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Lehuen, J. Diana, P. Zaccone, and A. Cooke, “Immune cell crosstalk in type 1 diabetes,” Nature Reviews Immunology, vol. 10, no. 7, pp. 501–513, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Mallone, V. Brezar, and C. Boitard, “T cell recognition of autoantigens in human type 1 diabetes: clinical perspectives,” Clinical and Developmental Immunology, vol. 2011, Article ID 513210, 16 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Bending, P. Zaccone, and A. Cooke, “Inflammation and type one diabetes,” International Immunology, vol. 24, no. 6, pp. 339–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Cnop, N. Welsh, J. C. Jonas, A. Jörns, S. Lenzen, and D. L. Eizirik, “Mechanisms of pancreatic β-cell death in type 1 and type 2 diabetes: many differences, few similarities,” Diabetes, vol. 54, no. 2, pp. 97–107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. D. L. Eizirik and T. Mandrup-Poulsen, “A choice of death – the signal-transduction of immune-mediated beta-cell apoptosis,” Diabetologia, vol. 44, no. 12, pp. 2115–2133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. Y. L. Lightfoot, J. Chen, and C. E. Mathews, “Immune-mediated β-cell death in type 1 diabetes: lessons from human β-cell lines,” European Journal of Clinical Investigation, vol. 42, no. 11, pp. 1244–1251, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. A. V. Matveyenko and P. C. Butler, “Relationship between β-cell mass and diabetes onset,” Diabetes, Obesity and Metabolism, vol. 10, no. 4, pp. 23–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. S. L. Fink and B. T. Cookson, “Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells,” Infection and Immunity, vol. 73, no. 4, pp. 1907–1916, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Lizarbe, “El suicidio y la muerte celular,” Revista de la Real Academia de Ciencias Exactas, Físicas y Naturales, vol. 101, no. 2, pp. 419–454, 2007. View at Google Scholar
  55. W. Chaabane, S. D. User, M. El-Gazzah et al., “Autophagy, apoptosis, mitoptosis and necrosis: interdependence between those pathways and effects on cancer,” Archivum Immunologiae et Therapiae Experimentalis, vol. 61, no. 1, pp. 43–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Duprez, E. Wirawan, T. Vanden Berghe, and P. Vandenabeele, “Major cell death pathways at a glance,” Microbes and Infection, vol. 11, no. 13, pp. 1050–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Chandra, B. Zhivotovsky, S. Zaitsev, L. Juntti-Berggren, P. O. Berggren, and S. Orrenius, “Role of apoptosis in pancreatic beta-cell death in diabetes,” Diabetes, vol. 50, Supplement 1, pp. S44–S47, 2001. View at Google Scholar
  58. E. N. Gurzov and D. L. Eizirik, “Bcl-2 proteins in diabetes: mitochondrial pathways of β-cell death and dysfunction,” Trends in Cell Biology, vol. 21, no. 7, pp. 424–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Zhou, Y. Yang, and D. Xing, “Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis,” The FEBS Journal, vol. 278, no. 3, pp. 403–413, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Eisenberg-Lerner, S. Bialik, H. U. Simon, and A. Kimchi, “Life and death partners: apoptosis, autophagy and the cross-talk between them,” Cell Death & Differentiation, vol. 16, no. 7, pp. 966–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. H. Hui, F. Dotta, U. Di Mario, and R. Perfetti, “Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death,” Journal of Cellular Physiology, vol. 200, no. 2, pp. 177–200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. D. Choil and M. Wool, “Executioners of apoptosis in pancreatic β-cells: not just for cell death,” American Journal of Physiology-Endocrinology and Metabolism, vol. 298, pp. 735–741, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. S. B. Sahin, S. Cetinkalp, M. Erdogan, C. Yilmaz, and A. Berdeli, “Fas, Fas Ligand, and vitamin D receptor FokI gene polymorphisms in patients with type 1 diabetes mellitus in the Aegean region of Turkey,” Genetic Testing and Molecular Biomarkers, vol. 16, no. 10, pp. 1179–1183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Maher, D. Toomey, C. Condron, and D. Bouchier-Hayes, “Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack,” Immunology and Cell Biology, vol. 80, no. 2, pp. 131–137, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. J. Park, S. Lee, T. J. Kieffer et al., “Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide,” Diabetologia, vol. 55, no. 4, pp. 1035–1047, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. A. R. Hamad, K. Arcara, S. Uddin, and T. Donner, “The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes,” Frontiers in Immunology, vol. 3, p. 196, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Gabay, C. Lamacchia, and G. Palmer, “IL-1 pathways in inflammation and human diseases,” Nature Reviews Rheumatology, vol. 6, no. 4, pp. 232–241, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Wali, S. Masters, and H. Thomas, “Linking metabolic abnormalities to apoptotic pathways in beta cells in type 2 diabetes,” Cells, vol. 2, no. 2, pp. 266–283, 2013. View at Publisher · View at Google Scholar
  69. F. Ortis, M. Miani, M. L. Colli et al., “Differential usage of NF-κB activating signals by IL-1β and TNF-α in pancreatic beta cells,” FEBS Letters, vol. 586, no. 7, pp. 984–989, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. T. Lawrence, “The nuclear factor NF-κB pathway in inflammation,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 6, article a001651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. Wang, Y. Zhu, L. Gao et al., “Formononetin attenuates IL-1β-induced apoptosis and NF-κB activation in INS-1 cells,” Molecules, vol. 17, no. 12, pp. 10052–10064, 2012. View at Publisher · View at Google Scholar · View at Scopus
  72. U. Zumsteg, S. Frigerio, and G. A. Holländer, “Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine beta-cell damage,” Diabetes, vol. 49, no. 1, pp. 39–47, 2010. View at Google Scholar
  73. A. J. F. King, Y. Guo, D. Cai et al., “Sustained NF-κB activation and inhibition in β-cells have minimal effects on function and islet transplant outcomes,” PLoS ONE, vol. 8, no. 10, article e77452, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. C. Wang, Y. Guan, and J. Yang, “Cytokines in the progression of pancreatic β-cell dysfunction,” International Journal of Endocrinology, vol. 2010, Article ID 515136, 10 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?” Diabetes, vol. 52, no. 1, pp. 1–8, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. M. Miani, J. Barthson, M. L. Colli, F. Brozzi, M. Cnop, and D. L. Eizirik, “Endoplasmic reticulum stress sensitizes pancreatic beta cells to interleukin-1β-induced apoptosis via Bim/A1 imbalance,” Cell Death & Disease, vol. 4, no. 7, article e701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Wu and B. P. Zhou, “TNF-α/NF-κB/snail pathway in cancer cell migration and invasion,” British Journal of Cancer, vol. 102, no. 4, pp. 639–644, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Barthson, C. M. Germano, F. Moore et al., “Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation,” The Journal of Biological Chemistry, vol. 286, no. 45, pp. 39632–39643, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Croft, C. A. Benedict, and C. F. Ware, “Clinical targeting of the TNF and TNFR superfamilies,” Nature Reviews Drug Discovery, vol. 12, no. 2, pp. 147–168, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. L. Vincenz, E. Szegezdi, R. Jäger, C. Holohan, T. O’Brien, and A. Samali, “Cytokine-induced β-cell stress and death in type 1 diabetes mellitus,” in Type 1 Diabetes - Complications, Pathogenesis, and Alternative Treatments, C.-P. Liu, Ed., InTech Editorial, 2011. View at Publisher · View at Google Scholar
  81. G. W. Dorn, “Mechanisms of non-apoptotic programmed cell death in diabetes and heart failure,” Cell Cycle, vol. 9, no. 17, pp. 3442–3448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  82. E. W. Lee, J. Seo, M. Jeong, S. Lee, and J. Song, “The roles of FADD in extrinsic apoptosis and necroptosis,” BMB Reports, vol. 45, no. 9, pp. 496–508, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. F. K. Chan, J. Shisler, J. G. Bixby et al., “A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses,” The Journal of Biological Chemistry, vol. 51, pp. 51613–51621, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Kaczmarek, P. Vandenabeele, and D. V. Krysko, “Necroptosis: the release of damage-associated molecular patterns and its physiological relevance,” Immunity, vol. 38, no. 2, pp. 209–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. D. E. Christofferson and J. Yuan, “Necroptosis as an alternative form of programmed cell death,” Current Opinion in Cell Biology, vol. 22, no. 2, pp. 263–268, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. M. V. Jain, A. M. Paczulla, T. Klonisch et al., “Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development,” Journal of Cellular and Molecular Medicine, vol. 17, no. 1, pp. 12–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer, “Molecular mechanisms of necroptosis: an ordered cellular explosion,” Nature Reviews Molecular Cell Biology, vol. 11, no. 10, pp. 700–714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Fulda, “Alternative cell death pathways and cell metabolism,” International Journal of Cell Biology, vol. 2013, Article ID 463637, 4 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. L. Galluzzi and G. Kroemer, “Necroptosis: a specialized pathway of programmed necrosis,” Cell, vol. 135, no. 7, pp. 1161–1163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. B. Williams, “Insulin resistance: the shape of things to come,” The Lancet, vol. 344, no. 8921, pp. 521–524, 1994. View at Publisher · View at Google Scholar · View at Scopus
  91. C. J. Lynch and S. H. Adams, “Branched-chain amino acids in metabolic signalling and insulin resistance,” Nature Reviews Endocrinology, vol. 10, no. 12, pp. 723–736, 2014. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Jang, S. F. Oh, S. Wada et al., “A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance,” Nature Medicne, vol. 22, no. 4, pp. 421–426, 2016. View at Publisher · View at Google Scholar · View at Scopus
  93. P. Diiorio, A. Jurczyk, C. Yang et al., “Hyperglycemia-induced proliferation of adult human beta cells engrafted into spontaneously diabetic immunodeficient NOD-Rag1null IL2rγnull Ins2Akita mice,” Pancreas, vol. 40, no. 7, pp. 1147–1149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. N. Kaiser, G. Leibowitz, and R. Nesher, “Glucotoxicity and β-cell failure in type 2 diabetes mellitus,” Journal of Pediatric Endocrinology and Metabolism, vol. 16, no. 1, pp. 5–22, 2003. View at Publisher · View at Google Scholar
  95. M. Bensellam, D. R. Laybutt, and J. C. Jonas, “The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions,” Molecular and Cellular Endocrinology, vol. 364, no. 1-2, pp. 1–27, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. X. Du, T. Matsumura, D. Edelstein et al., “Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells,” The Journal of Clinical Investigation, vol. 112, no. 7, pp. 1049–1057, 2003. View at Publisher · View at Google Scholar
  97. K. V. Ramana, B. Friedrich, R. Tammali, M. B. West, A. Bhatnagar, and S. K. Srivastava, “Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells,” Diabetes, vol. 54, no. 3, pp. 818–829, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. G. Leibowitz, E. Bachar, M. Shaked et al., “Glucose regulation of β-cell stress in type 2 diabetes,” Diabetes, Obesity and Metabolism, vol. 12, Supplement 2, pp. 66–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. C. M. Oslowski and F. Urano, “A switch from life to death in endoplasmic reticulum stressed β-cells,” Diabetes, Obesity and Metabolism, vol. 12, Supplement 2, pp. 58–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. J. E. Schaffer, “Fatty acid transport: the roads taken,” American Journal of Physiology-Endocrinology and Metabolism, vol. 282, no. 2, pp. E239–E246, 2002. View at Publisher · View at Google Scholar
  101. W. El-Assaad, J. Buteau, M. L. Peyot et al., “Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death,” Endocrinology, vol. 144, no. 9, pp. 4154–4163, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Giacca, C. Xiao, A. I. Oprescu, A. C. Carpentier, and G. F. Lewis, “Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies,” American Journal of Physiology-Endocrinology and Metabolism, vol. 300, no. 2, pp. E255–E262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  103. V. Poitout and R. P. Robertson, “Glucolipotoxicity: fuel excess and β-cell dysfunction,” Endocrine Reviews, vol. 29, no. 3, pp. 351–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. E. Boslem, P. J. Meikle, and T. J. Biden, “Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction,” Islets, vol. 4, no. 3, pp. 177–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. D. A. Cunha, P. Hekerman, L. Ladrière et al., “Initiation and execution of lipotoxic ER stress in pancreatic β-cells,” Journal of Cell Science, vol. 121, no. 14, pp. 2308–2318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. W. Gehrmann, M. Elsner, and S. Lenzen, “Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic β-cells,” Diabetes, Obesity and Metabolism, vol. 12, Supplement 2, pp. 149–158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  107. W. S. Cruz, G. Kwon, C. A. Marshall, M. L. McDaniel, and C. F. Semenkovich, “Glucose and insulin stimulate heparin-releasable lipoprotein lipase activity in mouse islets and INS-1 cells. A potential link between insulin resistance and β-cell dysfunction,” The Journal of Biological Chemistry, vol. 276, no. 15, pp. 12162–12168, 2001. View at Publisher · View at Google Scholar · View at Scopus
  108. K. Maedler, G. A. Spinas, D. Dyntar, W. Moritz, N. Kaiser, and M. Y. Donath, “Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function,” Diabetes, vol. 50, no. 1, pp. 69–76, 2001. View at Publisher · View at Google Scholar
  109. A. K. Busch, E. Gurisik, D. V. Cordery et al., “Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic β-cells from lipoapoptosis,” Diabetes, vol. 54, no. 10, pp. 2917–2924, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. F. Zaccardi, D. R. Webb, T. Yates, and M. J. Davies, “Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective,” Postgraduate Medical Journal, vol. 92, no. 1084, pp. 63–69, 2016. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Abedini and A. M. Schmidt, “Mechanisms of islet amyloidosis toxicity in type 2 diabetes,” FEBS Letters, vol. 587, no. 8, pp. 1119–1127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  112. H. R. Jeong and S. S. An, “Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus,” Clinical Interventions in Aging, vol. 10, pp. 1873–1879, 2015. View at Publisher · View at Google Scholar · View at Scopus
  113. S. G. Fonseca, M. Burcin, J. Gromada, and F. Urano, “Endoplasmic reticulum stress in beta-cells and development of diabetes,” Current Opinion in Pharmacology, vol. 9, no. 6, pp. 763–770, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. A. Martel, L. Antony, Y. Gerelli et al., “Membrane permeation versus amyloidogenicity: a multitechnique study of islet amyloid polypeptide interaction with model membranes,” Journal of the American Chemical Society, vol. 139, no. 1, pp. 137–148, 2017. View at Publisher · View at Google Scholar · View at Scopus
  115. L. Marzban, G. Trigo-Gonzalez, and C. B. Verchere, “Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of β cells,” Molecular Endocrinology, vol. 19, no. 8, pp. 2154–2163, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. J. Montane, A. Klimek-Abercrombie, K. J. Potter, C. Westwell-Roper, and C. B. Verchere, “Metabolic stress, IAPP and islet amyloid,” Diabetes, Obesity and Metabolism, vol. 14, no. 3, pp. 68–77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. C. J. Huang, C. Lin, L. Haataja et al., “High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress–mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes,” Diabetes, vol. 56, no. 8, pp. 2016–2027, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. P. Westermark, A. Andersson, and G. T. Westermark, “Islet amyloid polypeptide, islet amyloid, and diabetes mellitus,” Physiological Reviews, vol. 91, no. 3, pp. 795–826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. D. L. Eizirik, A. K. Cardozo, and M. Cnop, “The role for endoplasmic reticulum stress in diabetes mellitus,” Endocrine Reviews, vol. 29, no. 1, pp. 42–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Srinivasan, M. Ohsugi, Z. Liu, S. Fatrai, E. Bernal-Mizrachi, and M. A. Permutt, “Endoplasmic reticulum stress–induced apoptosis is partly mediated by reduced insulin signaling through phosphatidylinositol 3-kinase/Akt and increased glycogen synthase kinase-3β in mouse insulinoma cells,” Diabetes, vol. 54, no. 4, pp. 968–975, 2005. View at Publisher · View at Google Scholar · View at Scopus
  121. H. P. Harding, Y. Zhang, A. Bertolotti, H. Zeng, and D. Ron, “Perk is essential for translational regulation and cell survival during the unfolded protein response,” Molecular Cell, vol. 5, no. 5, pp. 897–904, 2000. View at Publisher · View at Google Scholar · View at Scopus
  122. G. Kroemer, G. Mariño, and B. Levine, “Autophagy and the integrated stress response,” Molecular Cell, vol. 40, no. 2, pp. 280–293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. H. Watada and Y. Fujitani, “Minireview: autophagy in pancreatic β-cells and its implication in diabetes,” Molecular Endocrinology, vol. 29, no. 3, pp. 338–348, 2015. View at Publisher · View at Google Scholar · View at Scopus
  124. D. J. Klionsky and S. D. Emr, “Autophagy as a regulated pathway of cellular degradation,” Science, vol. 290, no. 5497, pp. 1717–1721, 2000. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Masini, M. Bugliani, R. Lupi et al., “Autophagy in human type 2 diabetes pancreatic beta cells,” Diabetologia, vol. 52, no. 6, pp. 1083–1086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. A. Rocchi and C. He, “Emerging roles of autophagy in metabolism and metabolic disorders,” Frontiers in Biology, vol. 10, no. 2, pp. 154–164, 2015. View at Publisher · View at Google Scholar · View at Scopus
  127. I. Tanida, T. Ueno, and E. Kominami, “LC3 conjugation system in mammalian autophagy,” The International Journal of Biochemistry & Cell Biology, vol. 36, no. 12, pp. 2503–2518, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. P. M. Wong, C. Puente, I. G. Ganley, and X. Jiang, “The ULK1 complex: sensing nutrient signals for autophagy activation,” Autophagy, vol. 9, no. 2, pp. 124–137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. N. Hosokawa, T. Hara, T. Kaizuka et al., “Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy,” Molecular Biology of the Cell, vol. 20, no. 7, pp. 1981–1991, 2009. View at Publisher · View at Google Scholar · View at Scopus
  130. S. Di Bartolomeo, M. Corazzari, F. Nazio et al., “The dynamic interaction of AMBRA1 with the dynein motor complex regulates mammalian autophagy,” Journal of Cell Biology, vol. 191, no. 1, pp. 155–168, 2010. View at Publisher · View at Google Scholar · View at Scopus
  131. C. Burman and N. T. Ktistakis, “Regulation of autophagy by phosphatidylinositol 3-phosphate,” FEBS Letters, vol. 584, no. 7, pp. 1302–1312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. Kabeya, N. Mizushima, A. Yamamoto, S. Oshitani-Okamoto, Y. Ohsumi, and T. Yoshimori, “LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation,” Journal of Cell Science, vol. 117, Part 13, no. 13, pp. 2805–2812, 2004. View at Publisher · View at Google Scholar · View at Scopus
  133. H. S. Jung, K. W. Chung, J. Won Kim et al., “Loss of autophagy diminishes pancreatic β cell mass and function with resultant hyperglycemia,” Cell Metabolism, vol. 8, no. 4, pp. 318–324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. B. J. Marsh, C. Soden, C. Alarcón et al., “Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine β-cells,” Molecular Endocrinology, vol. 21, no. 9, pp. 2255–2269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Goginashvili, Z. Zhang, E. Erbs et al., “Insulin secretory granules control autophagy in pancreatic β cells,” Science, vol. 347, no. 6224, pp. 878–882, 2015. View at Publisher · View at Google Scholar · View at Scopus
  136. K. Komiya, T. Uchida, T. Ueno et al., “Free fatty acids stimulate autophagy in pancreatic β-cells via JNK pathway,” Biochemical and Biophysical Research Communications, vol. 401, no. 4, pp. 561–567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. L. Martino, M. Masini, M. Novelli et al., “Palmitate activates autophagy in INS-1E β-cells and in isolated rat and human pancreatic islets,” PLoS One, vol. 7, no. 5, article e36188, 2012. View at Publisher · View at Google Scholar · View at Scopus
  138. S. U. R. Mir, N. M. George, L. Zahoor, R. Harms, Z. Guinn, and N. E. Sarvetnick, “Inhibition of autophagic turnover in β-cells by fatty acids and glucose leads to apoptotic cell death,” The Journal of Biological Chemistry, vol. 290, no. 10, pp. 6071–6085, 2015. View at Publisher · View at Google Scholar · View at Scopus
  139. J. J. Wu, C. Quijano, E. Chen et al., “Mitochondrial dysfunction and oxidative stress mediate the physiological impairment induced by the disruption of autophagy,” Aging, vol. 1, no. 4, pp. 425–437, 2009. View at Publisher · View at Google Scholar
  140. W. Quan, K. Y. Hur, Y. Lim et al., “Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice,” Diabetologia, vol. 55, no. 2, pp. 392–403, 2012. View at Publisher · View at Google Scholar · View at Scopus
  141. J. F. Rivera, T. Gurlo, M. Daval et al., “Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions,” Cell Death & Differ, vol. 18, no. 3, pp. 415–426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  142. A. Bartolome, C. Guillen, and M. Benito, “Autophagy plays a protective role in endoplasmic reticulum stress-mediated pancreatic β cell death,” Autophagy, vol. 8, no. 12, pp. 1757–1768, 2012. View at Publisher · View at Google Scholar · View at Scopus
  143. C. Ebato, T. Uchida, M. Arakawa et al., “Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet,” Cell Metabolism, vol. 8, no. 4, pp. 325–332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  144. J. F. Rivera, S. Costes, T. Gurlo, C. G. Glabe, and P. C. Butler, “Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity,” The Journal of Clinical Investigation, vol. 124, no. 8, pp. 3489–3500, 2014. View at Publisher · View at Google Scholar · View at Scopus
  145. K. Fujimoto, P. T. Hanson, H. Tran et al., “Autophagy regulates pancreatic beta cell death in response to Pdx1 deficiency and nutrient deprivation,” The Journal of Biological Chemistry, vol. 284, no. 40, pp. 27664–27673, 2009. View at Publisher · View at Google Scholar · View at Scopus
  146. A. Ciechanover, “Proteolysis: from the lysosome to ubiquitin and the proteasome,” Nature Reviews Molecular Cell Biology, vol. 6, no. 1, pp. 79–87, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. T. Hartley, J. Brumell, and A. Volchuk, “Emerging roles for the ubiquitin-proteasome system and autophagy in pancreatic β-cells,” American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 1, pp. E1–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  148. S. Costes, C. Huang, T. Gurlo et al., “β-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide–induced UCH-L1 deficiency,” Diabetes, vol. 60, no. 1, pp. 227–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. C. Broca, E. Varin, M. Armanet et al., “Proteasome dysfunction mediates high glucose-induced apoptosis in rodent beta cells and human islets,” PLoS ONE, vol. 9, no. 3, article e92066, 2014. View at Publisher · View at Google Scholar · View at Scopus
  150. S. A. Litwak, J. A. Wali, E. G. Pappas et al., “Lipotoxic stress induces pancreatic β-cell apoptosis through modulation of Bcl-2 proteins by the ubiquitin-proteasome system,” Journal of Diabetes Research, vol. 2015, Article ID 280615, 16 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  151. C. M. Larsen, M. Faulenbach, A. Vaag et al., “Interleukin-1-receptor antagonist in type 2 diabetes mellitus,” The New England Journal of Medicine, vol. 356, no. 15, pp. 1517–1526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  152. T. Bergsbaken, S. L. Fink, and B. T. Cookson, “Pyroptosis: host cell death and inflammation,” Nature Reviews Microbiology, vol. 7, no. 2, pp. 99–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  153. B. G. Byrne, J. F. Dubuisson, A. D. Joshi, J. J. Persson, and M. S. Swanson, “Inflammasome components coordinate autophagy and pyroptosis as macrophage responses to infection,” MBio, vol. 4, no. 1, pp. e00620–e00612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  154. E. A. Miao, J. V. Rajan, and A. Aderem, “Caspase-1-induced pyroptotic cell death,” Immunological Reviews, vol. 243, no. 1, pp. 206–214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  155. H. Wen, D. Gris, Y. Lei et al., “Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling,” Nature Immunology, vol. 12, no. 5, pp. 408–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. N. Saïd-Sadier and D. M. Ojcius, “Alarmins, inflammasomes and immunity,” Biomed Journal, vol. 35, no. 6, pp. 437–449, 2012. View at Publisher · View at Google Scholar · View at Scopus
  157. F. S. Sutterwala, S. Haasken, and S. L. Cassel, “Mechanism of NLRP3 inflammasome activation,” Annals of the New York Academy of Sciences, vol. 1319, no. 1, pp. 82–95, 2014. View at Publisher · View at Google Scholar · View at Scopus
  158. S. K. Vanaja, V. A. K. Rathinam, and K. A. Fitzgerald, “Mechanisms of inflammasome activation: recent advances and novel insights,” Trends in Cell Biology, vol. 25, no. 5, pp. 308–315, 2015. View at Publisher · View at Google Scholar · View at Scopus
  159. C. S. Shi, K. Shenderov, N. N. Huang et al., “Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction,” Nature Immunology, vol. 13, no. 3, pp. 255–263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  160. N. Jounai, K. Kobiyama, M. Shiina, K. Ogata, K. J. Ishii, and F. Takeshita, “NLRP4 negatively regulates autophagic processes through an association with beclin1,” The Journal of Immunology, vol. 186, no. 3, pp. 1646–1655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  161. Y. H. Youm, A. Adijiang, B. Vandanmagsar, D. Burk, A. Ravussin, and V. D. Dixit, “Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage,” Endocrinology, vol. 152, no. 11, pp. 4039–4045, 2011. View at Publisher · View at Google Scholar · View at Scopus
  162. C. J. Tack, R. Stienstra, L. A. B. Joosten, and M. G. Netea, “Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family,” Immunological Reviews, vol. 249, no. 1, pp. 239–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  163. M. Böni-Schnetzler, J. Thorne, G. Parnaud et al., “Increased interleukin (IL)-1β messenger ribonucleic acid expression in β-cells of individuals with type 2 diabetes and regulation of IL-1β in human islets by glucose and autostimulation,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 10, pp. 4065–4074, 2008. View at Publisher · View at Google Scholar · View at Scopus
  164. R. Zhou, A. Tardivel, B. Thorens, I. Choi, and J. Tschopp, “Thioredoxin-interacting protein links oxidative stress to inflammasome activation,” Nature Immunology, vol. 11, no. 2, pp. 136–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. N. Welsh, M. Cnop, I. Kharroubi et al., “Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?” Diabetes, vol. 54, no. 11, pp. 3238–3244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  166. S. L. Masters, A. Dunne, S. L. Subramanian et al., “Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes,” Nature Immunology, vol. 11, no. 10, pp. 897–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  167. H. A. Arafat, A. K. Katakam, G. Chipitsyna et al., “Osteopontin protects the islets and β-cells from interleukin-1 β-mediated cytotoxicity through negative feedback regulation of nitric oxide,” Endocrinology, vol. 148, no. 2, pp. 575–584, 2007. View at Publisher · View at Google Scholar · View at Scopus
  168. R. Eldor, A. Yeffet, K. Baum et al., “Conditional and specific NF-κB blockade protects pancreatic beta cells from diabetogenic agents,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 13, pp. 5072–5077, 2006. View at Publisher · View at Google Scholar · View at Scopus
  169. B. Luo, B. Li, W. Wang et al., “NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model,” PLoS One, vol. 9, no. 8, article e104771, 2014. View at Publisher · View at Google Scholar · View at Scopus
  170. B. Luo, B. Li, W. Wang et al., “Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model,” Cardiovascular Drugs and Therapy, vol. 28, no. 1, pp. 33–43, 2014. View at Publisher · View at Google Scholar · View at Scopus
  171. S. Lee, E. Choi, M. J. Cha, and K. C. Hwang, “Looking for pyroptosis-modulating miRNAs as a therapeutic target for improving myocardium survival,” Mediators of Inflammation, vol. 2015, Article ID 254871, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  172. L. Galluzzi, M. C. Maiuri, I. Vitale et al., “Cell death modalities: classification and pathophysiological implications,” Cell Death and Differentiation, vol. 14, no. 7, pp. 1237–1243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  173. D. J. Taatjes, B. E. Sobel, and R. C. Budd, “Morphological and cytochemical determination of cell death by apoptosis,” Histochemistry and Cell Biology, vol. 129, no. 1, pp. 33–43, 2008. View at Publisher · View at Google Scholar · View at Scopus
  174. R. B. G. Ravelli, R. D. Kalicharan, M. C. Avramut et al., “Destruction of tissue, cells and organelles in type 1 diabetic rats presented at macromolecular resolution,” Scientific Reports, vol. 3, no. 1, p. 1804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  175. M. Masini, L. Martino, L. Marselli et al., “Ultrastructural alterations of pancreatic beta cells in human diabetes mellitus,” Diabetes/Metabolism Research and Reviews, vol. 33, no. 6, article e2894, 2017. View at Publisher · View at Google Scholar · View at Scopus
  176. L. Galluzzi, I. Vitale, J. M. Abrams et al., “Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012,” Cell Death and Differentiation, vol. 19, no. 1, pp. 107–120, 2012. View at Publisher · View at Google Scholar · View at Scopus
  177. L. Galluzzi, S. A. Aaronson, J. Abrams et al., “Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes,” Cell Death and Differentiation, vol. 16, no. 8, pp. 1093–1107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  178. M. Anello, R. Lupi, D. Spampinato et al., “Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients,” Diabetologia, vol. 48, no. 2, pp. 282–289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  179. P. Marchetti, M. Bugliani, R. Lupi et al., “The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients,” Diabetologia, vol. 50, no. 12, pp. 2486–2494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  180. L. Stiles and O. S. Shirihai, “Mitochondrial dynamics and morphology in beta-cells,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 26, no. 6, pp. 725–738, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. P. Marchetti, F. Dotta, D. Lauro, and F. Purrello, “An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment,” Regulatory Peptides, vol. 146, no. 1–3, pp. 4–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  182. P. Marchetti, M. Bugliani, V. De Tata, M. Suleiman, and L. Marselli, “Pancreatic beta cell identity in humans and the role of type 2 diabetes,” Frontiers in Cell and Developmental Biology, vol. 5, p. 55, 2017. View at Publisher · View at Google Scholar
  183. H. L. Hayes, B. S. Peterson, J. M. Haldeman, C. B. Newgard, H. E. Hohmeier, and S. B. Stephens, “Delayed apoptosis allows islet β-cells to implement an autophagic mechanism to promote cell survival,” PLoS ONE, vol. 12, no. 2, article e0172567, 2017. View at Publisher · View at Google Scholar · View at Scopus
  184. Z. F. Chen, Y. B. Li, J. Y. Han et al., “The double-edged effect of autophagy in pancreatic beta cells and diabetes,” Autophagy, vol. 7, no. 1, pp. 12–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  185. H. Kono, Y. Kimura, and E. Latz, “Inflammasome activation in response to dead cells and their metabolites,” Current Opinion in Immunology, vol. 30, pp. 91–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  186. M. R. de Zoete, N. W. Palm, S. Zhu, and R. A. Flavell, “Inflammasomes,” Cold Spring Harbor Perspectives in Biology, vol. 6, no. 12, article a016287, 2014. View at Publisher · View at Google Scholar · View at Scopus
  187. K. Maedler, P. Sergeev, F. Ris et al., “Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets,” The Journal of Clinical Investigation, vol. 110, no. 6, pp. 851–860, 2002. View at Publisher · View at Google Scholar · View at Scopus
  188. M. Igoillo-Esteve, L. Marselli, D. A. Cunha et al., “Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes,” Diabetologia, vol. 53, no. 7, pp. 1395–1405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  189. L. Håversen, K. N. Danielsson, L. Fogelstrand, and O. Wiklund, “Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages,” Atherosclerosis, vol. 202, no. 2, pp. 382–393, 2009. View at Publisher · View at Google Scholar · View at Scopus
  190. A. K. Cardozo, F. Ortis, J. Storling et al., “Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2+ ATPase 2b and deplete endoplasmic reticulum Ca2+, leading to induction of endoplasmic reticulum stress in pancreatic β-cells,” Diabetes, vol. 54, no. 2, pp. 452–461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  191. P. Pirot, D. L. Eizirik, and A. K. Cardozo, “Interferon-γ potentiates endoplasmic reticulum stress-induced death by reducing pancreatic beta cell defence mechanisms,” Diabetologia, vol. 49, no. 6, pp. 1229–1236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  192. K. Nakahira, J. A. Haspel, V. A. Rathinam et al., “Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome,” Nature Immunology, vol. 12, no. 3, pp. 222–230, 2011. View at Publisher · View at Google Scholar · View at Scopus